Transfusion

Article	Citations
Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID‐19) pandemic affecting Washington State	129
COVID‐19 and ABO blood groups	78
SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission	67
Use of convalescent plasma inCOVID‐19 patients with immunosuppression	64
Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program	54
Characteristics and serological patterns of COVID‐19 convalescent plasma donors: optimal donors and timing of donation	51
SARS‐CoV‐2 seroprevalence among blood donors after the first COVID‐19 wave in Canada	45
The use of low‐titer group O whole blood is independently associated with improved survival compared to component therapy in adults with severe traumatic hemorrhage	44
Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey	43
Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing	41
COVID‐19 associated with severe autoimmune hemolytic anemia	41
SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance	41
Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity	40
COVID‐19 convalescent plasma: Interim recommendations from the AABB	38
Blood transfusion utilization in hospitalized COVID‐19 patients	36
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review	36
Survey of group A plasma and low‐titer group O whole blood use in trauma resuscitation at adult civilian level 1 trauma centers in the US	36
Supply and demand for plasma‐derived medicinal products ‐ A critical reassessment amid the COVID‐19 pandemic	36
Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma	36
How did we rapidly implement a convalescent plasma program?	35
Is SARS‐CoV‐2 transfusion transmitted?	35
Expansion of hospital‐based blood collections in the face of COVID‐19 associated national blood shortage	34
Nicotine exposure increases markers of oxidant stress in stored red blood cells from healthy donor volunteers	33
Convalescent plasma to treat coronavirus disease 2019 (COVID‐19): considerations for clinical trial design	33
Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light	33

Exploring predictors of Australian community members' blood donation intentions and blood donation–related behavior during the COVID‐19 pandemic	33
How do I manage severe postpartum hemorrhage?	33
Prehospital whole blood reduces early mortality in patients with hemorrhagic shock	33
Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—A systematic review and meta‐analysis	32
Association of ABO blood group and secretor phenotype with severe COVID‐19	32
Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: A systematic review and meta‐analysis	32
Donor‐dependent aging of young and old red blood cell subpopulations: Metabolic and functional heterogeneity	30
Blood donor obesity is associated with changes in red blood cell metabolism and susceptibility to hemolysis in cold storage and in response to osmotic and oxidative stress	29
Impact of taurine on red blood cell metabolism and implications for blood storage	28
Transition from room temperature to cold‐stored platelets for the preservation of blood inventories during the COVID‐19 pandemic	28
Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine	28
The current state of the platelet supply in the US and proposed options to decrease the risk of critical shortages	28
An international survey on the use of low titer group O whole blood for the resuscitation of civilian trauma patients in 2020	27
Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction	27
HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men	26
ABO blood group and risk of COVID‐19 infection and complications: A systematic review and meta‐analysis	26
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID‐19 convalescent plasma donors	25
Transfusion‐related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module — United States, 2013–2018	25
Extension of platelet shelf life with an improved bacterial testing algorithm	24
Ethyl glucuronide, a marker of alcohol consumption, correlates with metabolic markers of oxidant stress but not with hemolysis in stored red blood cells from healthy blood donors	24
Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality	24
Outcomes and management of immune thrombocytopenia secondary to COVID‐19: Cleveland clinic experience	24
Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction	24
First results of a ferritin‐based blood donor deferral policy in the Netherlands	23
Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion‐Transmissible	23
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals	23
Testosterone replacement therapy in blood donors modulates erythrocyte metabolism and susceptibility to hemolysis in cold storage	23
Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin‐induced thrombocytopenia: A systematic review	23
Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers	23
A retrospective study assessing the characteristics of COVID‐19 convalescent plasma donors and donations	23
A typology of blood donor motivations	23
No evidence of SARS‐CoV‐2 RNA among blood donors: A multicenter study in Hubei, China	23
A comparison of platelet function in cold‐stored whole blood and platelet concentrates	23
Cold storage of platelets in platelet additive solution maintains mitochondrial integrity by limiting initiation of apoptosis‐mediated pathways	22
Novel multiple swab method enables high efficiency in SARS‐CoV‐2 screenings without loss of sensitivity for screening of a complete population	22
Adverse events after low titer group O whole blood versus component product transfusion in pediatric trauma patients: A propensity‐matched cohort study	22
Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity	22
The impact of COVID‐19 on academic productivity by female physicians and researchers in transfusion medicine	22
Basic principles of viscoelastic testing	22
Quantifying dynamic range in red blood cell energetics: Evidence of progressive energy failure during storage	21
COVID‐19 convalescent plasma: phase 2	21
Convalescent plasma: possible therapy for novel coronavirus disease 2019	21
Persistence of SARS‐CoV‐2 nasopharyngeal swab PCR positivity in COVID‐19 convalescent plasma donors	21
Supplemental findings of the 2019 National Blood Collection and Utilization Survey	21
Machine learning–based prediction of transfusion	20
Injured recipients of low‐titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single‐center, retrospective study	20
How we secured a COVID‐19 convalescent plasma procurement scheme in Japan	20
Maintaining adequate donations and a sustainable blood supply: Lessons learned	20
Refractory thrombotic thrombocytopenic purpura related to checkpoint inhibitor immunotherapy	20
SARS‐CoV‐2 neutralization and serology testing of COVID‐19 convalescent plasma from donors with nonsevere disease	20

De novo acquired hemophilia as an immune dysregulation phenomenon following SARS‐CoV‐2 infection	20
Feasibility of a pilot program for COVID‐19 convalescent plasma collection in Wuhan, China	20
Stored RBC metabolism as a function of caffeine levels	20
Neutralizing and binding activities against SARS‐CoV‐1/2, MERS‐CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived	19
Clinical data for intravenous iron – debunking the hype around hypersensitivity	19
Donor screening question alternatives to men who have sex with men time deferral: Potential impact on donor deferral and discomfort	19
Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study	19
Cold‐stored whole blood in a Norwegian emergency helicopter service: an observational study on storage conditions and product quality	19
Transfusion practices in a large cohort of hospitalized children	19
The impact of temporary deferrals on future blood donation behavior across the donor life cycle	19
Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh‐frozen plasma	19
Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations	18
The Swedish Scandinavian donations and transfusions database (SCANDAT3‐S) – 50 years of donor and recipient follow‐up	18
Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay	18
Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid‐19	18
Joint Trauma System, Defense Committee on Trauma, and Armed Services Blood Program consensus statement on whole blood	18
Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction	18
Lewis and ABO histo‐blood types and the secretor status of patients hospitalized with COVID‐19 implicate a role for ABO antibodies in susceptibility to infection with	18
Blood component utilization in COVID‐19 patients in New York City: Transfusions do not follow the curve	18
Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety?	18
The strengths and weaknesses of viscoelastic testing compared to traditional coagulation testing	18
A Delphi study to establish consensus on a definition of major bleeding in adult trauma	17
Trend in ABO‐incompatible RBC transfusion‐related fatalities reported to the FDA, 2000‐2019	17
The transfusion management of beta thalassemia in the United States	17
Babesia blood testing: the first‐year experience	17
A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with	16
Hematologic evaluation of intraoperative autologous blood collection and allogeneic transfusion in cardiac surgery	16
Minipool testing for SARS‐CoV‐2 RNA in United States blood donors	16
The compensatory reserve: potential for accurate individualized goal‐directed whole blood resuscitation	16
Transfusion support in COVID‐19 patients: Impact on hospital blood component supply during the outbreak	16
Selecting COVID‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV‐2 antibody assay	16
Effects of Intercept pathogen reduction treatment on extended cold storage of apheresis platelets	16
The Recipient Epidemiology and Donor Evaluation Study‐IV‐Pediatric (REDS‐IV‐P): A research program striving to improve blood donor safety and optimize transfusion outcomes across	16
Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study	16
Individual‐ and hospital‐level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States	16
Convalescent plasma treatment of critically ill intensive care COVID‐19 patients	15
Additive effects of blood donor smoking and gamma irradiation on outcome measures of red blood cell transfusion	15
A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin‐mediated hemolysis	15
The impact of ABO blood groups on clinical outcomes and susceptibility to COVID‐19: A retrospective study in an unselected population	15
The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients	15
Blood use and transfusion needs at a large health care system in Washington state during the SARS‐CoV‐2 pandemic	15
Plasmavigilance—Adverse events among US Source plasma donors	15
How do I manage long‐term blood component shortages in a hospital transfusion service?	15
Are We Forgetting About IgA? A Re‐examination of Coronavirus Disease 2019 Convalescent Plasma	15
Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis	15
Transfusion reactions associated with COVID‐19 convalescent plasma therapy for SARS‐CoV‐2	15
HIV incidence and compliance with deferral criteria over three progressively shorter time deferrals for men who have sex with men in Canada	14
Viscoelastic testing in COVID‐19: a possible screening tool for severe disease?	14
The effect of COVID‐19 on blood donation habits	14
Improved survival in critically injured combat casualties treated with fresh whole blood by forward surgical teams in Afghanistan	14
Retention of hemostatic and immunological properties of frozen plasma and COVID‐19 convalescent apheresis fresh‐frozen plasma produced and freeze‐dried in Canada	14
ABO blood type association with SARS‐CoV‐2 infection mortality: A single‐center population in New York City	14
New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS‐CoV‐2	14
Transfusion of blood components containing ABO‐incompatible plasma does not lead to higher mortality in civilian trauma patients	14
Refrigeration of apheresis platelets in platelet additive solution (PAS‐E) supports in vitro platelet quality to maximize the shelf‐life	14
How do we use electronic clinical decision support and feedback to promote good transfusion practice	14
Transfusion‐associated hyperkalemia in pediatric population: Prevalence, risk factors, survival, infusion rate, and RBC unit features	14
Development of a flow standard to enable highly reproducible measurements of deformability of stored red blood cells in a microfluidic device	14
Anti‐SARS‐CoV‐2 spike antibodies are stable in convalescent plasma when stored at 4° Celsius for at least 6 weeks	14
Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed	13
Whole truths but half the blood: Addressing the gap between the evidence and practice of pre‐hospital and in‐hospital blood product use for trauma resuscitation	13
Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic	13
Development and validation of donor adverse reaction severity grading tool: enhancing objective grade assignment to donor adverse events	13
A trend of dropping anti‐SARS‐CoV‐2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors	13
How do I establish a stool bank for fecal microbiota transplantation within the blood‐ and tissue transplant service?	13
Persistent viral RNA shedding after COVID‐19 symptom resolution in older convalescent plasma donors	13
How do I implement a whole blood–based blood preparedness program in a small rural hospital?	13
A large cohort study of the effects of Lewis, ABO, 13 other blood groups, and secretor status on COVID‐19 susceptibility, severity, and long COVID‐19	13
Hemolytic markers following the transfusion of uncrossmatched, cold‐stored, low‐titer, group O+ whole blood in civilian trauma patients	13
COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms	12
Blood group O convalescent plasma donations have significantly lower levels of SARS‐CoV‐2 IgG antibodies compared to blood group A donations	12
Bacterial contamination and septic transfusion reaction rates associated with platelet components before and after introduction of primary culture: experience at a US Academic Medical Center 1991 thro	12
Blood donor recruitment in Guangzhou, China, during the 2019 novel coronavirus (COVID‐19) epidemic	12
Improving the donation experience and reducing venipuncture pain by addressing fears among whole‐blood and plasma donors	12
Validation of predictive models identifying patients at risk for massive transfusion during liver transplantation and their potential impact on blood bank resource utilization	12
Antioxidant prevents clearance of hemostatically competent platelets after long‐term cold storage	12
Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery	12
Assessing predictors of futility in patients receiving massive transfusions	12
Current state of whole blood transfusion for civilian trauma resuscitation	12
How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?	12

Multi‐national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome	12
Calcium chelation: a novel approach to reduce cryopreservation‐induced damage to frozen platelets	12
Detection of BabesiaRNA and DNA in whole blood samples from US blood donations	12
A comparison between leukocyte reduced low titer whole blood vs non‐leukocyte reduced low titer whole blood for massive transfusion activation	12
Financial analysis of large‐volume delayed sampling to reduce bacterial contamination of platelets	12
Donation related fears predict vasovagal reactions and donor attrition among high school donors	12
The healthy donor effect and survey participation, becoming a donor and donor career	12
Factors that influence flow through intravascular catheters: the clinical relevance of Poiseuille's law	11
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study	11
COVID‐19: are neutralizing antibodies neutralizing enough?	11
Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness	11
Massive transfusions and severe hypocalcemia: An opportunity for monitoring and supplementation guidelines	11
Risk of hematological malignancy in blood donors: A nationwide cohort study	11
Extended storage of thawed platelets: Refrigeration supports postthaw quality for 10 days	11
Safety profile of low‐titer group O whole blood in pediatric patients with massive hemorrhage	11
Is placental blood a reliable source for the evaluation of neonatal hemostasis at birth?	11
Residual bacterial detection rates after primary culture as determined by secondary culture and rapid testing in platelet components: A systematic review and meta‐analysis	11
Trans people and blood donation	11
The use of cryopreserved platelets in a trauma‐induced hemorrhage model	11
Trends in hepatitis E virus infection: Analyses of the long‐term screening of blood donors in Hokkaido, Japan, 2005–2019	11
High‐throughput detection of antibodies targeting the SARS‐CoV‐2 Spike in longitudinal convalescent plasma samples	11
Impact of COVID‐19 and lockdown regarding blood transfusion	11
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID‐19 pandemic	11
Efficacy and safety of high‐dose intravenous iron as the first‐choice therapy in outpatients with severe iron deficiency anemia	11
A case study of 10 patients administered HBOC‐201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option	11
Improvements and limitations in developing multivariate models of hemorrhage and transfusion risk for the obstetric population	11
A prospective multi‐faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study	10
Initial experimental experience of triple‐knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease	10
Neonatal and pediatric blood bank practice in the United States: Results from the AABB pediatric transfusion medicine subsection survey	10
Removal of citrate from PAS‐III additive solution improves functional and biochemical characteristics of buffy‐coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reductio	10
Continued stabilization of blood collections and transfusions in the United States: Findings from the 2021 National Blood Collection and Utilization Survey	10
Donation‐induced iron depletion is significantly associated with low hemoglobin at subsequent donations	10
Effect of repeat transfusion exposure on plasma cytokine and markers of endothelial activation in the extremely preterm neonate	10
Racial differences in red blood cell transfusion in hospitalized patients with anemia	10
Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission	10
Peri‐transfusion quality‐of‐life assessment for patients with myelodysplastic syndromes	10
Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluatio	10
Retrospective analysis of outcomes in patients with acute hypertriglyceridemic pancreatitis treated without therapeutic plasma exchange	10
Non‐invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy	10
Sickle cell anemia and COVID‐19: Use of voxelotor to avoid transfusion	10
Intraosseous transfusion of hemoglobin vesicles in the treatment of hemorrhagic shock with collapsed vessels in a rabbit model	10
Tranexamic acid: Beyond antifibrinolysis	10
Malaria parasitemia among blood donors in Uganda	10
Complement‐mediated hemolysis persists year round in patients with cold agglutinin disease	10
Bringing new plasma donors back: testing the efficacy of telephone and e‐mail communications with first‐time donors	10
Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta‐thalassemia in Taiwan: A real‐world analysis	10
A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets	10
Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram	10
Quality of evidence‐based guidelines for platelet transfusion and use: A systematic review	10
Evaluation of a pre‐exposure prophylaxis (PrEP)/post‐exposure prophylaxis (PEP) deferral policy among blood donors	10
From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization	10
Tools for rapid analysis of blood usage and inventory during the COVID‐19 pandemic	10
RH genotyping by nonspecific quantitative next‐generation sequencing	10
Red cell exchange for patients with sickle cell disease: an international survey of current practices	10
Validation of PLASMIC score: an academic medical center case series (2012‐present)	10
Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice	10
The burden of immune‐mediated refractoriness to platelet transfusions in myelodysplastic syndromes	10
Targeted exome sequencing designed for blood group, platelet, and neutrophil antigen investigations: Proof‐of‐principle study for a customized single‐test system	10
Multidisciplinary management of anti‐PP1Pk or anti‐P alloimmunization during pregnancy: A new case with anti‐P and a literature review	10
Google Trends as an early indicator for shortages of intravenous immunoglobulin (IVIG)	10
Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far	9
Impact of the early coronavirus disease 2019 pandemic on blood utilization in the United States: A time‐series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module	9
Hypocalcemia as a predictor of mortality and transfusion. A scoping review of hypocalcemia in trauma and hemostatic resuscitation	9
CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non‐Hodgkinʼs lymphoma patients: results of the prospective multicenter GOA study	9
Trauma‐induced hypocalcemia	9
Demographic, clinical, and biochemical predictors of pica in a large cohort of blood donors	9
Multiple GYPB gene deletions associated with the U− phenotype in those of African ancestry	9
Transfusion services operations during the COVID‐19 pandemic: Results from AABB survey	9
Pandemic blood donor demographics – Do changes impact blood safety?	9
Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands	9
What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation	9
Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations	9
Metabolic rejuvenation upgrades circulatory functions of red blood cells stored under blood bank conditions	9
Preoperative erythropoietin within a patient blood management program decreases both blood transfusion and postoperative anemia: a prospective observational study	9
Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro	9
A randomized controlled trial of a tablet‐based intervention to address predonation fears among high school donors	9
Factors associated with registrant availability for unrelated adult donor hematopoietic stem cell donation: Analysis of the stem cell registry at Canadian Blood Services	9
Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant	9
Platelet dysfunction after trauma: From mechanisms to targeted treatment	9
Rethinking the need for a platelet transfusion threshold of 50 × 109/L for lumbar puncture in cancer patients	9
Trends and risk factors of SARS‐CoV‐2 infection in asymptomatic blood donors	9
Civilian walking blood bank emergency preparedness plan	9
Familial pseudohyperkalemia induces significantly higher levels of extracellular potassium in early storage of red cell concentrates without affecting other standard measures of quality: A case contro	9
Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction	9
Mouse background genetics in biomedical research: The devil's in the details	9
The need for an artificial oxygen carrier for disasters and pandemics, including COVID‐19	9
Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles	9
Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy	9
Undisclosed HIV status and antiretroviral therapy use among South African blood donors	9
Hospital transfusion service operations during the SARS‐CoV‐2 pandemic: Lessons learned from the AABB hospital survey in preparation for the next infectious disease outbreak	9
Safety and benefits of automated red cell depletion‐exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion	9
The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus‐6B encephalitis after naïve T‐cell‐depleted allogeneic stem cel	9
Insights intoanti‐Dformation in carriers ofRhDvariants through studies of3Dintraprotein interactions	9
X‐ and gamma‐irradiation have similar effects on the in vitro quality of stored red cell components	8
Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization	8